Neumeier Poma Investment Counsel LLC Raises Stake in Huron Consulting Group Inc. $HURN

Neumeier Poma Investment Counsel LLC lifted its stake in shares of Huron Consulting Group Inc. (NASDAQ:HURN) by 11.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 272,845 shares of the business services provider’s stock after acquiring an additional 28,527 shares during the quarter. Huron Consulting Group makes up approximately 3.5% of Neumeier Poma Investment Counsel LLC’s holdings, making the stock its 8th biggest position. Neumeier Poma Investment Counsel LLC owned about 1.58% of Huron Consulting Group worth $37,527,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Quarry LP bought a new stake in shares of Huron Consulting Group in the first quarter worth about $31,000. CWM LLC lifted its position in shares of Huron Consulting Group by 55.9% during the first quarter. CWM LLC now owns 407 shares of the business services provider’s stock worth $58,000 after purchasing an additional 146 shares during the last quarter. Vestcor Inc bought a new position in Huron Consulting Group in the 1st quarter worth about $60,000. SBI Securities Co. Ltd. increased its holdings in Huron Consulting Group by 725.5% during the 2nd quarter. SBI Securities Co. Ltd. now owns 421 shares of the business services provider’s stock worth $58,000 after purchasing an additional 370 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Huron Consulting Group in the first quarter valued at about $72,000. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

Huron Consulting Group Price Performance

HURN opened at $161.00 on Wednesday. The company has a current ratio of 1.44, a quick ratio of 1.99 and a debt-to-equity ratio of 1.18. Huron Consulting Group Inc. has a 12-month low of $116.77 and a 12-month high of $174.26. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of 26.97 and a beta of 0.28. The stock’s 50-day moving average price is $152.37 and its 200 day moving average price is $143.34.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings data on Tuesday, October 28th. The business services provider reported $2.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.24. The business had revenue of $441.28 million during the quarter, compared to analysts’ expectations of $418.13 million. Huron Consulting Group had a return on equity of 27.06% and a net margin of 6.54%.The business’s quarterly revenue was up 16.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.68 EPS. Huron Consulting Group has set its FY 2025 guidance at 7.600-7.700 EPS. As a group, sell-side analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current year.

Insider Buying and Selling at Huron Consulting Group

In related news, COO James Ronald Dail sold 7,824 shares of Huron Consulting Group stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $169.53, for a total value of $1,326,402.72. Following the sale, the chief operating officer directly owned 31,184 shares in the company, valued at $5,286,623.52. The trade was a 20.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director James H. Roth sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $164.13, for a total value of $328,260.00. Following the sale, the director directly owned 37,304 shares in the company, valued at $6,122,705.52. This trade represents a 5.09% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 17,808 shares of company stock worth $2,823,525. 2.15% of the stock is owned by company insiders.

Analysts Set New Price Targets

HURN has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Huron Consulting Group from a “hold” rating to a “buy” rating in a research note on Saturday, November 1st. Benchmark raised their price target on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Truist Financial upped their target price on Huron Consulting Group from $180.00 to $240.00 and gave the stock a “buy” rating in a research note on Friday, November 14th. Barrington Research raised their target price on Huron Consulting Group from $173.00 to $176.00 and gave the company an “outperform” rating in a research report on Thursday, August 7th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Huron Consulting Group in a report on Wednesday, October 8th. Six investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $190.25.

Huron Consulting Group Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.